ABSTRACT
The aim of the study was to investigate self-reported health-related quality of life (HRQOL) in children and adolescents with myelomeningocele (MMC) and to examine the impact of clinical impairments and limitations in activities of daily living (ADL). Fifty patients (28 females, 22 males) between 8 and 16 years of age (mean age 12y 1mo [SD 2y 4mo]) with MMC from three German paediatric centres and their mothers completed standardized measures on HRQOL (KINDL-R) and limitations in ADL (Childhood Health Assessment Questionnaire). Lesion level was thoracic in nine, sacral in 25, and lumbosacral in 11 patients. Twenty-one patients were community walkers, 17 were able to walk in the home, and seven used a wheelchair. Two-thirds had health problems related to the central nervous system causing current difficulties (eight patients had a shunt, six had hydrocephalus, and 10 had a tethered cord). Patients in the study group reported diminished overall HRQOL compared with norm data, specifically in the dimensions of emotional well-being, self-esteem, and peer relations. Adolescents reported diminished HRQOL in the dimension of peer relations. Most medical parameters as well as limitations in ADL were not significantly associated with HRQOL. Our findings confirm the results of studies which dispute a linear inverse association between condition severity and HRQOL and emphasize the importance of peer relations in young patients with MMC.
Subject(s)
Health Status , Meningomyelocele/psychology , Quality of Life/psychology , Surveys and Questionnaires , Adolescent , Child , Demography , Female , Humans , Male , Meningomyelocele/epidemiology , Self ConceptABSTRACT
OBJECTIVE: The purpose of this study was to assess the efficacy of fluoxetine, a selective serotonergic antidepressant, in the treatment of dysthymia. METHOD: Thirty-five patients who met criteria for dysthymia, but not major depression, began randomized, double-blind 8-week trials of fluoxetine or placebo. RESULTS: Of 32 patients who completed the study, 10 (62.5%) of the 16 patients given fluoxetine and three (18.8%) of the 16 given placebo responded to treatment. Response was defined as 1) 50% or greater decrease in Hamilton Rating Scale for Depression score and 2) a score of 1 or 2 on the Clinical Global Impression (CGI) improvement subscale. Fluoxetine subjects showed significantly greater improvement at week 8 than placebo subjects on the Hamilton depression and CGI scales, but not on the Hopkins Symptom Check-list (58-item) or the Cornell Dysthymia Rating Scale. CONCLUSIONS: When compared to placebo, fluoxetine showed short-term effectiveness in treating dysthymic symptoms.
Subject(s)
Depressive Disorder/drug therapy , Fluoxetine/therapeutic use , Adult , Depressive Disorder/psychology , Double-Blind Method , Female , Humans , Male , Personality Inventory , Placebos , Psychiatric Status Rating ScalesABSTRACT
Several adapted rigid contact lens wearers were given duplicates of their present lenses made in different plastics. They were required to wear each material on each eye for a period of four hours. Both the average wetting angle and its range of values for each material was compiled. All lenses tended to give similar average wetting angles but ranges of angles for the PMMA/siloxanyl materials were greater than that for PMMA and GP IITM. Both values should be utilized when evaluating the wettability of a specific material.
Subject(s)
Contact Lenses , Surface-Active Agents , Wetting Agents , Humans , Methods , Optometry/instrumentation , Plastics , Time FactorsABSTRACT
A new contact lens design fabricated from the POLYCON(R) material was evaluated. The patient population were predominately successful and unsuccessful contact lens wearers. Successful wearing criteria were established in the protocol and the results were tabulated accordingly. The successfully fitted patients represented 90.4%.
